Literature DB >> 12565105

Effect of hormone replacement therapy on tissue factor activity, C-reactive protein, and the tissue factor pathway inhibitor.

Kwang Kon Koh1, Jeong Yeal Ahn, Dae Sung Kim, Seung Hwan Han, Mi-Seung Shin, Won Seok Ryu, Gi Soo Park, Tae Hoon Ahn, In Suck Choi, Eak Kyun Shin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12565105     DOI： 10.1016/s0002-9149(02)03176-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  2 in total

1.  Low levels of tissue factor pathway inhibitor increase the risk of cerebral venous thrombosis.

Authors:  Shaghayegh Haghjooy Javanmard; Tayebeh Shahsavarzadeh; Mohammad Saadatnia
Journal:  Adv Biomed Res       Date:  2015-01-06

2.  Risk of venous thromboembolic disease in postmenopausal women taking oral or transdermal hormone replacement therapy.

Authors:  Barbara Ruszkowska; Grażyna Gadomska; Liliana Bielis; Marzena Gruszka; Barbara Góralczyk; Danuta Rość; Grażyna Odrowąż-Sypniewska
Journal:  J Zhejiang Univ Sci B       Date:  2011-01       Impact factor: 3.066
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.